Morning Market Movers

Alnylam Pharmaceuticals (NASDAQ: ALNY ) rose 34.16% to $88.83 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK ). Genzyme and Alnylam expanded their collaboration on rare genetic diseases. Rexahn Pharmaceuticals (NYSE: RNN ) jumped 33.77% to $1.53. Rexahn Pharmaceuticals shares